Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Regeneron Pharmaceuticals (NQ: REGN )

823.38 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, Sep 21, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 2
Open 823.38
Bid (Size) 768.14 (1)
Ask (Size) 897.48 (1)
Prev. Close 823.38
Today's Range 823.38 - 823.38
52wk Range 668.00 - 847.50
Shares Outstanding 91,779,465
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Analyst Expectations for Regeneron Pharmaceuticals's Future
Via Benzinga
This Recent FDA Approval Could Give Regeneron's Top Line a Big Boost
A higher-dose version of Eylea will help the company fight off competition and increase revenue. 
Via The Motley Fool
Exposures Product Safety

Performance

YTD
+14.28%
+14.28%
1 Month
-2.05%
-2.05%
3 Month
+5.59%
+5.59%
6 Month
+2.65%
+2.65%
1 Year
+20.27%
+20.27%

More News

Read More
3 Stocks to Buy to Ride Europe’s Coming Market Surge
Via InvestorPlace
Regeneron Pharmaceuticals Inc. (NASDAQ: REGN) is a Leading Gainer in 9/19 Morning Trading
Via Investor Brand Network
$100 Invested In This Stock 5 Years Ago Would Be Worth $200 Today
Via Benzinga
Peering Into Regeneron Pharmaceuticals's Recent Short Interest
Via Benzinga
Check Out What Whales Are Doing With REGN
Via Benzinga
Regeneron Pharmaceuticals Inc. (NASDAQ: REGN) is a Leading Gainer in 9/8 Morning Trading
Via Investor Brand Network
If You Invested $100 In This Stock 20 Years Ago, You Would Have $4,000 Today
Via Benzinga
Looking At Regeneron Pharmaceuticals's Recent Unusual Options Activity
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 15, 2023
Via Benzinga
AI Integration In Biotech & Pharma: Companies Positioned To Benefit
Via Benzinga
Topics Artificial Intelligence
Exposures Artificial Intelligence
Check Out What Whales Are Doing With REGN
Via Benzinga
Is Regeneron Stock a Buy Now?
Via The Motley Fool
New to Investing? Here's How You Can Get Started With $500.
Via The Motley Fool
3 Unstoppable Growth Stocks to Buy Right Now
Via The Motley Fool
Regeneron Provides Update on Planned Chief Financial Officer Transition
From Regeneron Pharmaceuticals, Inc.
Via GlobeNewswire
Regeneron Announces Updates to Board of Directors
From Regeneron Pharmaceuticals, Inc.
Via GlobeNewswire
2 Top Biotech Stocks to Buy in September
Via The Motley Fool
Could This Biosimilar Drug Be Novartis' Next Blockbuster?
Via The Motley Fool
Is REGENERON PHARMACEUTICALS (NASDAQ:REGN) suited for quality investing?
Via Chartmill
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Acer Therapeutics Inc. (Nasdaq - ACER), Sovos Brands, Inc. (Nasdaq - SOVO), Computer Task Group, Incorporated (Nasdaq - CTG), Decibel Therapeutics, Inc. (Nasdaq -
From Brodsky & Smith LLC
Via GlobeNewswire
Small Cancer Therapy Player Celularity To Provide Research Support For Regeneron's Therapy
Via Benzinga
Wall Street Thinks This Tiny Biotech Company Could Soar Soon
Via The Motley Fool
These Are the ONLY 7 Penny Stocks to Consider in August 2023
Via InvestorPlace
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.